Published on
June 12, 2019
- 08:00 GMT
Allele Enters into Collaboration and Licensing Deal on its cGMP iPSC with Alpine BioTherapeutics for Vision Loss
Allele Biotechnology and Pharmaceuticals, Inc. and Alpine BioTherapeutics Corporation entered into a research agreement for developing iPSC-derived cell therapy SAN DIEGO, CA, USA, June 12, 2019 /EINPresswire.com/ -- San Diego, June 12, 2019--Allele …
Distribution channels:
Beauty & Hair Care, Food & Beverage Industry
...
